Vascular malformation: genes and variants
Explore variant evidence for Vascular malformation across 7 analyzed proteins (KRAS, BRAF, MAP2K1, GNA11, NRAS and 2 more). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Vascular malformation
KRAS: GTPase KRas
A small GTPase that acts as a molecular switch in the RAS-MAPK signaling pathway. By cycling between GDP- and GTP-bound states, it relays growth and survival signals, and activating KRAS variants are common drivers of cancer.
4 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in KRAS have source records linked to Vascular malformation. Association strength is not clinical gene validity.
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in BRAF have source records linked to Vascular malformation. Association strength is not clinical gene validity.
MAP2K1: Dual specificity mitogen-activated protein kinase kinase 1
It phosphorylates ERK1 and ERK2 downstream of RAF and thereby propagates RAS-MAPK growth and developmental signals. Activating somatic variants occur in several cancers, while germline activating variants can cause cardio-facio-cutaneous syndrome and related RASopathies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MAP2K1 have source records linked to Vascular malformation. Association strength is not clinical gene validity.
GNA11: Guanine nucleotide-binding protein subunit alpha-11
It transmits signals from Gq-coupled receptors to phospholipase C and downstream calcium and protein-kinase-C pathways. Germline activating variants can cause autosomal dominant hypocalcemia, while somatic activating variants drive uveal melanoma and some vascular lesions.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GNA11 have source records linked to Vascular malformation. Association strength is not clinical gene validity.
NRAS: GTPase NRas
Its active GTP-bound state drives RAF-MEK-ERK and PI3K signaling downstream of growth-factor receptors. Somatic activating variants are common drivers of melanoma, leukemia, and other cancers, while germline activating variants can cause Noonan syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NRAS have source records linked to Vascular malformation. Association strength is not clinical gene validity.
PIK3R1: Phosphatidylinositol 3-kinase regulatory subunit alpha
Its p85-family products stabilize and regulate class IA PI3K catalytic subunits and couple receptors to PI3K activation. Pathogenic variants can cause activated PI3K-delta syndrome type 2 or SHORT syndrome depending on how they alter pathway output.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PIK3R1 have source records linked to Vascular malformation. Association strength is not clinical gene validity.
IDH2: Isocitrate dehydrogenase [NADP], mitochondrial
It normally generates alpha-ketoglutarate and NADPH inside mitochondria. Recurrent R140 and R172 cancer-associated variants instead produce D-2-hydroxyglutarate, an oncometabolite that drives epigenetic dysregulation in acute myeloid leukemia and other tumors.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IDH2 have source records linked to Vascular malformation. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RASA1.
ClinVar pathogenic and likely pathogenic variants linked to Vascular malformation
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| BRAF G466R | 466 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| BRAF G469R | 469 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| KRAS Q22K | 22 | Pathogenic / likely pathogenic (★★) | |
| NRAS Q61R | 61 | Pathogenic / likely pathogenic (★★) | |
| MAP2K1 K57N | 57 | Pathogenic / likely pathogenic (★★) | |
| KRAS Q61R | 61 | Pathogenic / likely pathogenic (★) | |
| KRAS Q61H | 61 | Pathogenic / likely pathogenic (★) | |
| GNA11 R183C | 183 | G-alpha | Pathogenic / likely pathogenic (★) |
| PIK3R1 N564D | 564 | Pathogenic / likely pathogenic (★) | |
| KRAS G12S | 12 | Pathogenic / likely pathogenic | |
| IDH2 R172S | 172 | Pathogenic / likely pathogenic |
Which prediction tools work for Vascular malformation
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 98 out of 100
- ESM1b (LLR): 96 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 89 out of 100
- MutPred: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- RASopathy also has ClinVar records linked to KRAS variants; they fall partly in the same places as the Vascular malformation variants (23 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Vascular malformation variants (16 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to KRAS variants; they fall partly in the same places as the Vascular malformation variants (9 pathogenic / likely pathogenic).
- Autoimmune lymphoproliferative syndrome also has ClinVar records linked to KRAS variants; they fall partly in the same places as the Vascular malformation variants (5 pathogenic / likely pathogenic).
- Non-small cell lung carcinoma also has ClinVar records linked to KRAS variants; they fall partly in the same places as the Vascular malformation variants (5 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Vascular malformation variants (36 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Vascular malformation variants (26 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Vascular malformation variants (17 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Vascular malformation variants (11 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Vascular malformation variants (10 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to MAP2K1 variants; they fall mostly in different places as the Vascular malformation variants (14 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to MAP2K1 variants; they fall mostly in different places as the Vascular malformation variants (14 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to MAP2K1 variants; they fall mostly in different places as the Vascular malformation variants (6 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Vascular malformation variants (6 pathogenic / likely pathogenic).
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Vascular malformation variants (4 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to NRAS variants; they fall mostly in different places as the Vascular malformation variants (9 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to NRAS variants; they fall mostly in different places as the Vascular malformation variants (6 pathogenic / likely pathogenic).
Diseases related to Vascular malformation
- RASopathy, also linked to BRAF, KRAS, MAP2K1 and NRAS
- Noonan syndrome, also linked to BRAF, KRAS, MAP2K1 and NRAS
- Noonan syndrome and Noonan-related syndrome, also linked to BRAF, KRAS, MAP2K1 and NRAS
- Cardiofaciocutaneous syndrome, also linked to BRAF, KRAS, MAP2K1 and NRAS
- Hypertrophic cardiomyopathy, also linked to BRAF, MAP2K1 and NRAS
- Cardio-facio-cutaneous syndrome, also linked to BRAF, KRAS and MAP2K1
- Acute myeloid leukemia, also linked to IDH2, KRAS and NRAS
- Colorectal cancer, also linked to BRAF, KRAS and NRAS
- Non-small cell lung carcinoma, also linked to BRAF, KRAS and MAP2K1
- Costello syndrome, also linked to BRAF, MAP2K1 and NRAS
- Multiple myeloma, also linked to BRAF, KRAS and NRAS
- Melanoma, also linked to BRAF, MAP2K1 and NRAS
Frequently asked questions
Which genes have records linked to Vascular malformation?
This view contains 7 analyzed proteins: KRAS, BRAF, MAP2K1, GNA11, NRAS and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 18 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center